Article info
PDFClinical ethics
Paediatric deep brain stimulation: ethical considerations in malignant Tourette syndrome
- Correspondence to Dr Antonios Mammis, Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, NJ 07103, USA; mammisan{at}njms.rutgers.edu
Citation
Paediatric deep brain stimulation: ethical considerations in malignant Tourette syndrome
Publication history
- Received January 16, 2020
- Revised February 29, 2020
- Accepted March 27, 2020
- First published May 4, 2020.
Online issue publication
January 25, 2021
Article Versions
- Previous version (23 September 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Image-based analysis and long-term clinical outcomes of deep brain stimulation for Tourette syndrome: a multisite study
- Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation
- The Gilles De La Tourette syndrome: the current status
- Prevalence of nail biting and its chronological relationship with tics in child and adolescent outpatients with Tourette syndrome: a single-centre, retrospective observational study
- Differentiating tic electrophysiology from voluntary movement in the human thalamocortical circuit
- Neuronal activity in the globus pallidus internus in patients with tics
- Tourette’s syndrome and its borderland
- Gilles de la Tourette’s syndrome and its impact in the UK
- Beck Depression Inventory is a useful screening tool for major depressive disorder in Gilles de la Tourette syndrome
- Dissecting the Gilles de la Tourette spectrum: a factor analytic study on 639 patients